Table 1.
Datasets | Use | Platform | Number of patients | Outcome |
---|---|---|---|---|
GSE39582 | Meta‐training cohort | HG‐U133_Plus_2 | 579 | OS |
GSE17536 | Meta‐training cohort | HG‐U133_Plus_2 | 177 | OS |
GSE72970 | Meta‐training cohort | HG‐U133_Plus_2 | 124 | OS |
GSE38832 | Meta‐training cohort | HG‐U133_Plus_2 | 122 | DSS |
GSE39084 | Meta‐training cohort | HG‐U133_Plus_2 | 70 | OS |
GSE29621 | Meta‐training cohort | HG‐U133_Plus_2 | 65 | OS |
GSE17537 | Meta‐training cohort | HG‐U133_Plus_2 | 55 | OS |
TCGA | Independent testing cohort | Illumina HiSeq 2000 | 321 | OS |
GSE14333 | Independent testing cohort | HG‐U133_Plus_2 | 226 | DFS |
GSE33113 | Independent testing cohort | HG‐U133_Plus_2 | 89 | RFS |
Abbreviations: DFS, Disease‐free survival; DSS, Disease‐specific survival; OS, Overall survival; RFS, Recurrence‐free survival.